Kristen Sheppard | SVP, IR |
John Butler | President and CEO |
Steven Burke | Chief Medical Officer |
Jason Amello | CFO |
Allison Bratzel | Piper Sandler |
Eric Joseph | JPMorgan |
Difei Yang | Mizuho Securities |
Bert Hazlett | BTIG |
Chad Messer | Needham & Company |
Ed Arce | H.C. Wainwright |
David Lebowitz | Morgan Stanley |
Kennen MacKay | RBC Capital Markets |
Good morning, ladies and gentlemen, and welcome to the Akebia Therapeutics' INNO2VATE Top-line Data Readout Call and its First Quarter Financial Results and Business Highlights Conference Call.
As a reminder, this call is being recorded.
I would now like to introduce your host for today's conference, Kristen Sheppard.
Thank you, and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations at Akebia.